A Multicentre, Parallel Group, Randomised, Double Blind, Placebo Controlled Study of the Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress Disorder.
Phase of Trial: Phase III
Latest Information Update: 08 Dec 2010
At a glance
- Drugs Quetiapine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 14 Jul 2009 Trial phase changed from IV to III as reported by ClinicalTrials.gov.
- 14 Jul 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.